Overview |
bs-70104r-100ul |
GABAA Receptor ß2 Antibody |
WB |
Specific for endogenous levels of the ~55 kDa β2-subunit of the GABAA receptor. |
Mouse, Rat |
Human, Dog, Bovine, Non-Human Primate |
Specifications |
Unconjugated |
Rabbit |
Fusion protein from the cytoplasmic loop of the ß2 subunit of rat GABAA receptor. |
Polyclonal |
IgG |
Lot Dependent |
Antigen Affinity purification |
10 mM HEPES (pH 7.5), 150 mM NaCl, 100 µg per ml BSA and 50% glycerol. |
Storage at -20°C is recommended, as aliquots may be taken without freeze/thawing due to presence of 50% glycerol. Stable for at least 1 year at -20°C. |
Target |
25451 |
P63138 |
GABA antibody, GABA(A) receptor beta 2 antibody, GABA(A) receptor subunit beta-2 antibody, GABA-A receptor, beta-2 polypeptide antibody, GABRB2 antibody, Gamma aminobutyric acid (GABA) A receptor, beta 2 antibody, Gamma aminobutyric acid A receptor beta 2 antibody, Gamma-aminobutyric acid receptor subunit beta-2 antibody, Gamma-aminobutyric-acid receptor subunit beta-2 antibody, GBRB2_HUMAN antibody |
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, causing a hyperpolarization of the membrane through the opening of a Cl− channel associated with the GABA-A receptor (GABA-A-R) subtype. GABA-A-Rs are important therapeutic targets for a range of sedative, anxiolytic, and hypnotic agents and are implicated in several diseases including epilepsy, anxiety, depression, and substance abuse. The GABA-A-R is a multimeric subunit complex. To date six αs, four βs and four γs, plus alternative splicing variants of some of these subunits, have been identified (Olsen and Tobin, 1990; Whiting et al., 1999; Ogris et al., 2004). Injection in oocytes or mammalian cell lines of cRNA coding for α- and β-subunits results in the expression of functional GABA-A-Rs sensitive to GABA. However, coexpression of a γ-subunit is required for benzodiazepine modulation. The various effects of the benzodiazepines in brain may also be mediated via different α- subunits of the receptor (McKernan et al., 2000; Mehta and Ticku, 1998; Ogris et al., 2004; Pöltl et al., 2003). |
Application Dilution |
WB |
1:300-5000 |